Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 3301-3350 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT07061067
Affection of Symptoms Duration on Outcomes of Lumbar Spine Surgery
N/A
Recruiting
60 participants
Started: Jul 19, 2025 · Completed: Jan 1, 2026
3 conditions
1 sponsor
1 location
NCT06489041
Evaluating Microarray Pharmacogenetic Testing in Cancer Patients
NA
Recruiting
120 participants
Started: Jul 18, 2025 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06696365
iTBS for Alcohol Use Disorder
NA
Recruiting
42 participants
Started: Jul 18, 2025 · Completed: Feb 1, 2027
1 condition
1 sponsor
1 location
NCT06362161
Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND
N/A
Recruiting
1,100 participants
Started: Jul 18, 2025 · Completed: Dec 31, 2028
3 conditions
1 sponsor
1 location
NCT06973096
CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
PHASE1
Recruiting
9 participants
Started: Jul 18, 2025 · Completed: Jul 31, 2042
1 condition
1 sponsor
1 location
NCT06864754
WashU DIEP Flap Video and Patient Understanding Improvement
NA
Recruiting
300 participants
Started: Jul 18, 2025 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT07079631
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
PHASE1/PHASE2
Recruiting
482 participants
Started: Jul 18, 2025 · Completed: May 31, 2031
1 condition
2 sponsors
1 location
NCT06605105
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
PHASE3
Recruiting
468 participants
Started: Jul 18, 2025 · Completed: Mar 15, 2028
1 condition
2 sponsors
2 locations
NCT07126522
Virtual Support Platform (HERCaRE Application) for the Improvement of Survivorship Among Black Breast Cancer Survivors
NA
Recruiting
200 participants
Started: Jul 18, 2025 · Completed: Aug 1, 2027
1 condition
1 sponsor
1 location
NCT07011056
A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma
PHASE3
Recruiting
390 participants
Started: Jul 18, 2025 · Completed: Jun 30, 2029
1 condition
1 sponsor
1 location
NCT06929273
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
PHASE3
Recruiting
450 participants
Started: Jul 18, 2025 · Completed: Jun 13, 2028
1 condition
1 sponsor
141 locations
NCT06962631
V-IMMUNE® for Immune Thrombocytopenia
PHASE3
Recruiting
31 participants
Started: Jul 18, 2025 · Completed: Feb 27, 2027
1 condition
2 sponsors
2 locations
NCT07067346
Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma
EARLY_PHASE1
Recruiting
10 participants
Started: Jul 18, 2025 · Completed: Jun 30, 2026
1 condition
1 sponsor
2 locations
NCT04645602
Lenvatinib and Pembrolizumab Combination Therapy In HPV-associated Recurrent Respiratory Papillomatosis Patients With Laryngeal, Tracheal, and/or Pulmonary Involvement
PHASE2
Recruiting
20 participants
Started: Jul 18, 2025 · Completed: Dec 31, 2027
3 conditions
3 sponsors
1 location
NCT07070830
Simplified Onboarding in Adults With Type 2 Diabetes
NA
Recruiting
60 participants
Started: Jul 18, 2025 · Completed: Jan 31, 2026
1 condition
1 sponsor
6 locations
NCT06779630
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (BIOFLOW-48) Study
NA
Recruiting
150 participants
Started: Jul 18, 2025 · Completed: Sep 30, 2031
1 condition
2 sponsors
7 locations
NCT06708910
AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI
N/A
Recruiting
460 participants
Started: Jul 18, 2025 · Completed: Jul 31, 2031
1 condition
3 sponsors
1 location
NCT06950385
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
PHASE3
Recruiting
168 participants
Started: Jul 18, 2025 · Completed: Jan 31, 2031
1 condition
2 sponsors
5 locations
NCT07090330
ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis
PHASE2
Recruiting
80 participants
Started: Jul 18, 2025 · Completed: May 31, 2027
1 condition
1 sponsor
22 locations
NCT06468033
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
PHASE3
Recruiting
150 participants
Started: Jul 18, 2025 · Completed: Sep 30, 2028
2 conditions
1 sponsor
1 location
NCT07093476
Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
PHASE3
Recruiting
171 participants
Started: Jul 18, 2025 · Completed: Apr 30, 2027
3 conditions
1 sponsor
1 location
NCT06653647
Efficacy of Guided Imagery Therapy Mobile Application for Functional Abdominal Pain
NA
Recruiting
52 participants
Started: Jul 18, 2025 · Completed: Nov 30, 2025
10 conditions
2 sponsors
1 location
NCT07071402
A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery
NA
Recruiting
120 participants
Started: Jul 18, 2025 · Completed: Jun 1, 2029
1 condition
1 sponsor
1 location
NCT07071337
A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy
PHASE3
Recruiting
430 participants
Started: Jul 18, 2025 · Completed: Feb 28, 2031
1 condition
1 sponsor
2 locations
NCT07057596
Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma
PHASE2
Recruiting
19 participants
Started: Jul 18, 2025 · Completed: Dec 31, 2027
1 condition
2 sponsors
4 locations
NCT07113210
Quality of Life in Presbyopic Patients Who Are Treated With Qlosi
PHASE4
Recruiting
36 participants
Started: Jul 18, 2025 · Completed: Nov 15, 2025
3 conditions
1 sponsor
2 locations
NCT07063056
Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation
NA
Recruiting
64 participants
Started: Jul 18, 2025 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06676033
Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome
PHASE1
Recruiting
30 participants
Started: Jul 18, 2025 · Completed: Jul 1, 2027
2 conditions
1 sponsor
1 location
NCT06933329
Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer
PHASE2
Recruiting
73 participants
Started: Jul 18, 2025 · Completed: Feb 28, 2029
1 condition
1 sponsor
7 locations
NCT06926660
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
PHASE2
Recruiting
416 participants
Started: Jul 18, 2025 · Completed: Jan 8, 2027
1 condition
1 sponsor
162 locations
NCT06824168
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
PHASE2
Recruiting
130 participants
Started: Jul 18, 2025 · Completed: Jul 14, 2032
2 conditions
1 sponsor
57 locations
NCT06953089
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
PHASE2
Recruiting
492 participants
Started: Jul 18, 2025 · Completed: Jun 30, 2030
1 condition
2 sponsors
30 locations
NCT06635876
Caregivers Preparing for Their Own Health Care Emergency
NA
Recruiting
68 participants
Started: Jul 18, 2025 · Completed: Jun 30, 2026
2 conditions
2 sponsors
1 location
NCT07060573
Effects of Oral Stimulation Performed by Parents to Improve Sucking in Neonates Hospitalized in the NICU
NA
Recruiting
32 participants
Started: Jul 18, 2025 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT07032298
A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors
PHASE1
Recruiting
30 participants
Started: Jul 18, 2025 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT07058064
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
NA
Recruiting
250 participants
Started: Jul 18, 2025 · Completed: Jun 29, 2029
2 conditions
1 sponsor
1 location
NCT07187947
Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway
N/A
Recruiting
500 participants
Started: Jul 18, 2025 · Completed: Dec 31, 2035
7 conditions
1 sponsor
1 location
NCT07093463
Colon-delivered Riboflavin and Gut Microbiota Composition
NA
Recruiting
90 participants
Started: Jul 18, 2025 · Completed: Mar 31, 2026
2 conditions
2 sponsors
1 location
NCT06788587
Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder
PHASE2
Recruiting
80 participants
Started: Jul 18, 2025 · Completed: Dec 31, 2027
5 conditions
3 sponsors
1 location
NCT06455332
Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome
NA
Recruiting
200 participants
Started: Jul 17, 2025 · Completed: Jul 1, 2028
2 conditions
7 sponsors
1 location
NCT06900712
Positive Processes and Transition to Health - Single-Session (PATH-SS)
NA
Recruiting
45 participants
Started: Jul 17, 2025 · Completed: May 31, 2026
2 conditions
1 sponsor
1 location
NCT06867822
Trial of ProAgio in Advanced/Metastatic Colorectal Cancer
PHASE1
Recruiting
27 participants
Started: Jul 17, 2025 · Completed: Jul 31, 2028
2 conditions
2 sponsors
1 location
NCT06877273
Improving Cognitive Recovery in Multiple Sclerosis
NA
Recruiting
24 participants
Started: Jul 17, 2025 · Completed: Sep 15, 2026
1 condition
2 sponsors
1 location
NCT07078331
Safety and Performance, and Dose, of OsteoAdapt DE in Localized Alveolar Ridge Augmentations
PHASE1/PHASE2
Recruiting
45 participants
Started: Jul 17, 2025 · Completed: Jan 1, 2026
3 conditions
1 sponsor
3 locations
NCT06942221
Digital Solutions in Heart Therapy (DIGNITY)
NA
Recruiting
140 participants
Started: Jul 17, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT07000084
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
PHASE3
Recruiting
330 participants
Started: Jul 17, 2025 · Completed: Dec 5, 2028
3 conditions
2 sponsors
42 locations
NCT07212361
Infant Microbiota Restoration With Maternal Microbes
NA
Recruiting
100 participants
Started: Jul 17, 2025 · Completed: Dec 31, 2035
15 conditions
2 sponsors
2 locations
NCT07159607
Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR)
N/A
Recruiting
100 participants
Started: Jul 17, 2025 · Completed: Jul 16, 2030
1 condition
3 sponsors
2 locations
NCT06851754
Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency
EARLY_PHASE1
Recruiting
185 participants
Started: Jul 17, 2025 · Completed: Dec 31, 2031
1 condition
1 sponsor
1 location
NCT07077239
Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity
N/A
Recruiting
200 participants
Started: Jul 17, 2025 · Completed: Aug 1, 2036
1 condition
1 sponsor
1 location
Previous
1
More pages
64
65
66
67
68
69
70
More pages
1333
Next